Improving Early Recognition of ILD and the Management of IPF: Idiopathic Pulmonary Fibrosis: Developing Evidence-Based Management Plans
Medium: Online Presentation
Commerical Support: This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Target Audience
Learning Objectives
Upon completion of this activity, participants will be able to:
- Recognize risk factors for IPF;
- Use current evidence-based guidelines for the treatment of IPF to create individualized management strategies for patients with IPF;
- Describe conditions commonly found comorbidly with IPF and recognize the role of treating these conditions in a comprehensive IPF management plan.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation
COURSE FACULTY
Professor of Medicine
Director, University of Chicago
Interstitial Lung Disease Program
Chair, Pulmonary Fibrosis Foundation
Clinical Care Network Registry Ancillary Studies Committee
Chicago, IL
Professor of Medicine
Director, University of Michigan
Interstitial Lung Disease Program
Chair, Pulmonary Fibrosis Foundation Clinical Care Network/
Registry Steering Committee
Ann Arbor, MI
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and MCM Education. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other health care professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME, please consult your professional licensing board.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!